Funding news for global health researchers: June 15, 2026

On behalf of the Fogarty International Center at the U.S. National Institutes of Health (NIH), the following funding opportunities, notices and announcements may be of interest to those working in the field of global health research. Updates are typically distributed once a week.

Special Announcements

Fogarty welcomes new director, Dr. Steven Schiff, MD, PhD

Steven Schiff, MD, PhD, became the ninth director of the Fogarty International Center, and Associate Director for International Research at the National Institutes of Health (NIH), on June 4. A pediatric neurosurgeon, he was a professor at Yale University prior to joining Fogarty. Among his achievements in global health, he has worked toward the sustainable control of infant infections in lower-resource settings.

• Read the full press release from NIH
  

Fogarty seeks applications for International Health Program Officer

The Division of International Relations (DIR) at the Fogarty International Center is seeking an International Health Program Officer. The International Health Program Officer is responsible for all administrative, management, and policy development activities related to the implementation and coordination of NIH-supported biomedical research programs worldwide.

• International Health Program Officer - Open to the public
• Application deadline: June 19, 2026

Upcoming Deadlines for Fogarty Funding Opportunities

• Global Infectious Diseases (GID)
  Application deadline: August 6, 2026
  
• Emerging Global Leader
  Application deadline: December 3, 2026
  

Upcoming deadlines for all Fogarty funding opportunities

Funding opportunities on which Fogarty is a partner:

• Dissemination and Implementation Research in Health (R03 Clinical Trial Not Allowed) (PAR-25-233)
  Application due date: Multiple dates, see announcement.
• Dissemination and Implementation Research in Health (R21 Clinical Trial Optional) (PAR-25-143)
  Application due date: Multiple dates, see announcement.

Administrative supplements for current Fogarty grant recipients:

• Administrative Supplements to Existing NIH Grants and Cooperative Agreements (Parent Admin Supp Clinical Trial Optional) (PA-26-001)
  Expiration date: November 30, 2028
  

All administrative supplements

Funding Opportunities

NIH funding opportunities for which foreign organizations and/or foreign components of U.S. organizations may apply:

• HEAL Initiative: Limited Competition for the HEALthy Brain and Child Development Study - Research Project Sites (Collaborative U01- Clinical Trial Not Allowed) (RFA-DA-27-013)
  Application due date: July 10, 2026
• HEAL Initiative: Limited Competition for the HEALthy Brain and Child Development (HBCD) Study – Consortium Administrative Core and Data Coordinating Center (U24 Clinical Trial Not Allowed) (RFA-DA-27-014)
  Application due date: July 10, 2026
• Science Track Award for Research Transition (START) Program (R03, Clinical Trial Optional) (PAS-27-028)
  Application due date: Multiple dates, see announcement.
• Avant Garde/Avenir Awards for Investigators Conducting High Risk/High Reward Research on HIV and Substance Use (or Substance Use Disorders) (DP1 Clinical Trial Optional) (PAR-27-026)
  Application due date: Multiple dates, see announcement.
• Metastasis Research Network (U54 Clinical Trial Not Allowed) (RFA-CA-27-012)
  Application due date: September 25, 2026
• Advanced Development and Validation of Emerging Technologies for Basic and Clinical Cancer Research (R33 Clinical Trial Not Allowed) (RFA-CA-27-002)
  Application due date: Multiple dates, see announcement.
• Early-Stage Innovative Technology Development for Basic and Clinical Cancer Research (R61 Clinical Trial Not Allowed) (RFA-CA-27-001)
  Application due date: Multiple dates, see announcement.
• Biological Testing Facility for Contraception & Reproductive Health (X01 Clinical Trial Not Allowed) (PAR-27-111)
  Application due date: Multiple dates, see announcement.

NIH funding opportunities for which foreign components may apply:

• Limited Competition for the Adolescent Brain Cognitive Development -Extended (ABCD-E) Study Renewal - Data Analysis, Informatics and Resource Center, and Coordinating Center (U24 Clinical Trial Not Allowed) (RFA-DA-27-003)
  Application due date: July 9, 2026
• Limited Competition for the Adolescent Brain Cognitive Development -Extended (ABCD-E) Study-Research Project Sites (U01 Clinical Trial Not Allowed) (RFA-DA-27-002)
  Application due date: July 9, 2026
• Biomedical Technology Optimization and Dissemination Center (BTOD) (RM1 - Clinical Trial Not Allowed) (PAR-27-024)
  Application due date: Multiple dates, see announcement.
• Continuation of the Cardiovascular Repository for-Type 1 Diabetes (CARE-T1D) Consortium U01 (Open Competition)- Research (U01, Clinical Trial Not Allowed) (RFA-DK-27-108)
  Application due date: Multiple dates, see announcement.
• HEAL Initiative: Translating Addiction Epidemiology, Prevention, Treatment, and Recovery Research into Practice (R61/R33 - Clinical Trial Optional) (RFA-DA-27-016)
  Application due date: Multiple dates, see announcement.
• Paul Calabresi Career Development Award for Clinical Oncology (K12 Clinical Trial Not Allowed) (PAR-27-025)
  Application due date: Multiple dates, see announcement.

Other Funding News

Other funding updates that may be of interest to global health researchers.

General NIH notices:

• Notice of Pre-application Webinar for the NCI Community Oncology Research Program (NCORP) (NOT-CA-26-016)

Notices of changes to NIH funding opportunities:

• Notice of Extension of the Expiration Date for "Translational Research in Maternal and Pediatric Pharmacology and Therapeutics (R01 Clinical Trial Optional)" (NOT-HD-26-002)
  
• Notice of Extension of the Expiration Date for "Translational Research in Maternal and Pediatric Pharmacology and Therapeutics (R21 Clinical Trial Optional)" (NOT-HD-26-003)
• Notice of Early Expiration of PAR-25-342 "Interventions on Health and Healthcare Disparities on Non-Communicable and Chronic Diseases in Latin America: Improving Health Outcomes Across the Hemisphere (R01 - Clinical Trial Required)" (NOT-MD-26-001)
• Notice of Early Expiration of PAR-25-377 "Unveiling Health and Healthcare Disparities in Non-Communicable and Chronic Diseases in Latin America: Setting the Stage for Better Health Outcomes Across the Hemisphere (R01 - Clinical Trials Not Allowed)" (NOT-MD-26-002)
• Notice of Participation of the Environmental influences on Child Health Outcomes (ECHO) Program in PA-26-001 - Administrative Supplements to Existing NIH Grants and Cooperative Agreements (Parent Admin Supp Clinical Trial Optional) (NOT-OD-26-049)
• Notice of Extension for RFA-TR-25-002 "Preclinical Proof of Concept Studies for Rare Diseases (R21 Clinical Trial Not Allowed)" (NOT-TR-26-009)
• Notice of Early Expiration of PAR-25-319 "Advancing HIV/AIDS Research within the Mission of the NIDCD (R01 Clinical Trial Optional)" (NOT-DC-26-006)
• Notice of Change: Early Expiration of NINDS Ruth L. Kirschstein National Research Service Award (NRSA) for Training of Postdoctoral Fellows (F32 Clinical Trial Not Allowed) (NOT-NS-26-002)

Non-NIH funding opportunities:

• The Preclinical/Clinical Advancement of Cellular and Vaccine Therapies for Acral and Uveal Melanoma call for proposals funded by the Melanoma Research Alliance (MRA) through its Next Steps Program supports established researchers to accelerate the development of new approaches and technologies in cellular therapy and vaccine therapy for acral and/or uveal melanoma. Applications are open to applicants in the USA and worldwide.
  Application deadline: June 16, 2026
  
• The New treatments to tackle AMR - Treatments and adherence to treatment protocols supports researchers in South Africa in the Joint transnational call 2026 from the European Partnership on One Health Antimicrobial Resistance. Open to applicants worldwide.
  Application deadline: June 17, 2026
• The Eleventh GACD Funding Call – Multisectoral approaches from the Global Alliance for Chronic Diseases (GACD) supports international, collaborative research to tackle chronic non-communicable diseases (NCDs) in low- and middle-income countries and underserved populations in high-income countries. The call has a central focus on implementation research, exploring multisectoral strategies to improve prevention, diagnosis, screening, and management of NCDs for people living in low- and middle-income countries, and/or in underserved populations in high-income countries.
  Application deadline: June 17, 2026
• The Accelerator Awards support groundbreaking projects with the potential to transform neuroendocrine cancer research and treatment. Proposals should push the boundaries of innovation and foster synergistic collaboration across diverse scientific disciplines. Open to applicants worldwide.
  Application deadline: June 22, 2026
• The Amyotrophic Lateral Sclerosis Research Program - Clinical Outcomes and Biomarkers Award supports the development and/or validation of clinical outcomes and biomarkers to enrich clinical trials in Amyotrophic Lateral Sclerosis (ALS). Projects can be relevant to a specific therapy, a class of therapeutics, or to a specific ALS subtype (such as a particular genetic mutation) and do not have to broadly apply to all patients. The program is open to independent researchers in the USA and worldwide.
  Application deadline: June 24, 2026
• The Peer Reviewed Cancer Research Program - Clinical Trial Award from the Congressionally Directed Medical Research Programs (CDMRP) supports clinical trials that will advance previously completed preclinical research to the clinic, progress treatments to the next stage of study or improve the standard of care for individuals living with cancer. The program is open to researchers in the USA and worldwide.
  Pre-application deadline: June 26, 2026
• The Innovative Dermatology Education Award (IDEA) facilitates dermatologists' continuing education through support and development of innovative continuing medical education programs. Applications are open to organizations with the capacity to develop and deliver dermatology education. IDEA grants are awarded for programs that incorporate innovative teaching strategies or utilize innovative content delivery mechanisms.
  Application deadline: June 29, 2026
• The Myositis Association’s Meredith C. Thomas Memorial Fellowship supports a fellow pursuing a disease-specific, targeted project related to antisynthetase syndrome and/or interstitial lung disease. The fellowship prioritizes projects that advance understanding of cause, prevention, detection, treatment, or cure; work may also address health-related quality of life, symptom management, navigation of physical and mental health effects, and social impacts of illness. Open to applicants worldwide.
  Application deadline: June 29, 2026
• The Cure IBM Research Fund at The Myositis Association (TMA) offers this inaugural grant to advance basic science and mechanistic research into the biological basis of inclusion body myositis (IBM). Open to applicants worldwide.
  Application deadline: June 29, 2026
• Immune-Mediated Necrotizing Myopathy Research Grant advances research into the cause, prevention, detection, treatment, and cure of myositis and related diseases. This year’s grant cycle targets a disease-specific project related to immune-mediated necrotizing myopathy (IMNM), including its causes, disease processes, therapies, treatments, challenges, and quality-of-life impacts. Open to applicants worldwide.
  Application deadline: June 29, 2026
• The Gary S. Wasserman, DO, FAACT Memorial Pediatric Abstract Award recognizes one abstract accepted to the annual North American Congress of Clinical Toxicology (NACCT) on a topic in pediatric toxicology. The abstract must be submitted by a trainee (student, resident, clinical fellow, pre- or post-doctoral fellow) whose career interests include pediatric pharmacology and/or toxicology. Open to applicants worldwide.
  Application deadline: June 30, 2026
• The Frontiers of Knowledge Awards recognize world-class contributions to science, technology, the humanities, social sciences, and artistic creation. Open to applicants worldwide.
  Application deadline: June 30, 2026
• The Distinguished Contributions of Applications of Psychology to Education and Training recognizes psychologists for evidence-based applications of psychology to education. The candidate must demonstrate a contribution to new teaching methods or the solution of learning problems through the use of research findings or evidence-based practices. Open to applicants worldwide.
  Application deadline: July 1, 2026
• The Postdoctoral Fellowships from Breakthrough T1D support postdoctoral researchers in diabetes worldwide. This fellowship is intended for those at an early stage of their career. The award is for 3 years with the potential for 2 additional years.
  Application deadline: July 1, 2026
• The ATS-PHA Early Career Award supports the career of a junior investigator interested in pulmonary hypertension (PH) research who is likely to make a strong and sustained impact in PH research. Open to applicants worldwide.
  Application deadline: July 1, 2026
• The APA Award for Distinguished Contributions to the International Advancement of Psychology recognizes an individual who has made sustained and enduring contributions to international cooperation and the advancement of knowledge in psychology. Open to applicants worldwide.
  Application deadline: July 1, 2026
• The Tirone E. David International Fellowship supports international cardiac surgeons (within their first 14 years out of training) to support clinical observational training at a North American host institution and the opportunity to have a visiting cardiac surgeon-mentor provide training, education, or research support at the award recipient’s home institution. Applicants must be practicing cardiac surgeons or those enrolled in a cardiac surgery training program. The program strongly encourages applicants from low- and middle-income countries.
  Application deadline: July 2, 2026
• The BraYn Starting Grant 2026 supports innovative focused research projects in neuroscience. Applications are open to PhD students, postdoctoral researchers, medical residents, neurologists, and early-career researchers from anywhere in the world, within 3 years of their PhD award date. Applicants must have a valid contract until the end of the project, be registered for the BraYn 2026 conference, and be members of the BraYn Association.
  Application deadline: July 2, 2026
• The Young Investigator Award in Pediatric Brain Tumors provides funding to promising investigators to encourage and promote quality research in all focus areas of pediatric brain tumor research, with the goal of advancing the understanding and treatment of pediatric brain tumors. The Award is a mentored award and facilitates the transition from a trainee to an independent researcher. Open to applicants worldwide.
  Application deadline: July 15, 2026
• The Peer Reviewed Medical Research Program - Discovery Award supports novel, untested, high-risk, high-reward research projects with the potential to provide new insights, paradigms, technologies, or applications and with the potential to generate preliminary data that will lay the foundation for future projects. Applications must NOT include preliminary data. Open to applicants worldwide.
  Pre-application deadline: July 16, 2026
• The Peer Reviewed Medical Research Program - Research Advancement Award supports fundamental research studies that will make an important contribution towards research, patient care, and/or quality of life. Open to applicants worldwide.
  Pre-application deadline: July 16, 2026
• The Peer Reviewed Medical Research Program - Platform Clinical Translation Award supports the rapid implementation of clinical trials with the potential to have a significant impact on the treatment or management of a disease or condition. Open to applicants worldwide.
  Pre-application deadline: July 23, 2026
• The Peer Reviewed Medical Research Program - Impact Award supports applied research, defined as use-inspired and practice-oriented science that brings together outcomes from basic research, and insights from the real-world environment, to foster clinical applicability. The Impact Award intends to translate the fundamental understanding of underlying mechanisms toward solutions that have the potential for major near-term impact for patients. Open to applicants worldwide.
  Pre-application deadline: July 23, 2026
• The Tuberous Sclerosis Complex Research Program: Exploration-Hypothesis Development Award supports the initial exploration of innovative, high-risk, high-gain and potentially groundbreaking concepts in Tuberous Sclerosis Complex (TSC) research field. Clinical trials are not allowed. Open to applicants worldwide.
  Pre-application deadline: July 23, 2026
• The Vision Research Program - Translational Research Award supports translational research that moves promising discoveries into clinical applications that will advance the prevention, diagnosis, mitigation, and/or treatment of eye injury or visual dysfunction associated with military exposure. Open to applicants worldwide.
  Pre-application deadline: July 28, 2026
• The Macular Degeneration Research Grant provides funding for researchers worldwide with innovative research leading to greater understanding, prevention, and treatment of age-related macular degeneration. The Postdoctoral Fellowships from the Program are intended for researchers in the final stages of their mentored training and provide 100,000 USD/year for a period of 2 years. Open to applicants worldwide.
  Letters of intent deadline: July 30, 2026

More non-NIH funding opportunities

Events

Events of interest to global health researchers:

• Research That Heals: Partnering with Patients to Transform SCD Care

  • Date: June 25-26
  • Location: Rockville, MD (USA) and virtual
  • Hosted by the National Heart, Lung, and Blood Institute

• Oxford Global Health & Bioethics International Conference

  • Date: July 15-16
  • Location: Oxford, UK and Virtual
  • Hosted by the Oxford-Johns Hopkins Global Infectious Disease Ethics Collaborative
  • In association with the Global Health Bioethics Network and the University of Oxford Pandemic Sciences Institute

• Global Cancer Research and Control Seminar Series Webinar - Cancer Research Training in Low- and Middle-Income Countries (LMICs): Translation to U.S. Populations

  • Date: July 16
  • Location: Virtual
  • Hosted by the National Cancer Institute
    

Fogarty calendar of events